Patients with thrombotic disease are complex. Helping protect them against thrombosis doesn’t have to be.

For VTE prophylaxis in acutely ill medical patients at risk for thromboembolic complications who are not at high risk of bleeding.
CAD = coronary artery disease; CV = cardiovascular; DVT = deep vein thrombosis; NVAF = nonvalvular atrial fibrillation; PAD = peripheral artery disease; PE = pulmonary embolism; VTE = venous thromboembolism.

Intentionally developed to help protect against thrombotic events, providing unique versatility across the broadest range of patients in its class

  • Largest clinical development program of its class with more than 20 RCTs and 116,000-plus patients7-26
  • Dosing regimens optimized for each therapeutic indication
  • Proven efficacy and safety profile across the most indications – NVAF, chronic CAD/PAD, DVT/PE initial and extended treatment, VTE prophylaxis in acutely ill medical patients and after hip/knee replacement surgery